Accueil   Diary - News   All news Adocia successfully raises approx. €32m

Adocia successfully raises approx. €32m

Adocia, the clinical stage biotechnology company that specializes in the development of innovative formulations of already approved therapeutic proteins (the “Company”) today announces that it has raised €31.96m in gross proceeds through a private placement of new shares.

Adocia placed a total of 621,887 new shares of €0.10 nominal value each with domestic and healthcare specialist investors at a price of €51.40, representing a 5.17% discount to the volume weighted average price of the Adocia share on the regulated market of Euronext in Paris over the three trading days before pricing. The new shares represent 10% of the current number of outstanding shares and will bring the total number of shares after the issue to 6,840,763.

Read the press release